itinai content

  • AI News
  • AI Sales
  • Apple AI
  • Biohacking
  • Clinical Trials
  • Compare
  • Computer Vision
  • DeepSense
  • farma
  • Instruments
  • Management
  • Marketing
  • Marktechpost
  • Open AI
  • resume
  • КП
  • Deep Learning-Based Augmented Contrast-Enhancement and Denoising for Reduced-Iodine and Low-Radiation 70-kVp Cerebral CT Angiography: A Prospective Study

    1 мая, 2026

    CONCLUSION: Cerebral CTA at 70-kVp using ultralow iodine enhanced arterial attenuation but increased image noise compared with the 100-kVp CTA protocol. DL-ACE and DL-DN significantly increased arterial attenuation and reduced image noise, resulting in higher CNR and better subjective image quality. →

    Clinical Trials
  • Factors Affecting Technology Acceptance and Usability of a Personalized Online Nutrition and Exercise Web-Based App (Heal-Me): A Multimethods Study

    1 мая, 2026

    CONCLUSION: Performance expectancy emerged as the most influential factor predicting participants’ intention to use the Heal-Me web-based app, with findings clearly indicating a high level of acceptance of the first version of this technology. →

    Clinical Trials
  • Audit Yourself to Get More From GenAI

    1 мая, 2026

    Carolyn Geason-Beissel/MIT SMR | Getty Images More than a year into using generative AI daily, I wondered whether I was getting the most out of my AI use. There was no benchmark or feedback loop, and no one was grading my sessions with ChatGPT and Claude — until I created a self-audit. I did what… →

    Management
  • Effect of multicomponent exercise intervention on multidimensional frailty in older adults with mild cognitive impairment: a secondary analysis of the MIND-STEP randomised clinical trial

    30 апреля, 2026

    BACKGROUND: Frailty is common among older adults with mild cognitive impairment (MCI) and encompasses physical, cognitive, psychological and social domains, yet randomised evidence on theory-informed multicomponent exercise interventions targeting multidimensional frailty remains limited. This secondary analysis of the MIND-STEP RCT evaluated intervention effects across frailty domains. →

    Clinical Trials
  • Adjuvant administration probiotic effects on sexual function in depressant men undergoing selective serotonin reuptake inhibitor treatment: a double-blinded randomized controlled trial

    30 апреля, 2026

    CONCLUSION: Adding Lactofem to Escitalopram treatment significantly reduces depression severity and enhances sexual function in men with mild to moderate depression. →

    Clinical Trials
  • Combined Low-Level Laser and Ultrasound Therapy for Growing Pains in Children Aged Four to Twelve Years: A Pilot Study

    30 апреля, 2026

    Growing pains are a frequent form of musculoskeletal pain in children, with an uncertain etiology and currently limited therapeutic options. Considering the need for non-pharmacological approaches, the potential of low-level laser therapy combined with ultrasonic therapy stands out as a possible therapeutic technique for this condition. The objective of this study was to analyze the… →

    Clinical Trials
  • Diabetes Management by Ayurvedic Practitioners Using a Clinical Guideline Versus Usual Practice: A Feasibility Cluster Randomized Trial in Nepal

    30 апреля, 2026

    CONCLUSION: This feasibility trial demonstrated successful recruitment, follow-up, and intervention adherence. A definitive trial is feasible to evaluate the intervention’s effectiveness in T2DM management. →

    Clinical Trials
  • Leaders at All Levels: How Argenx Scaled to $4 Billion Without Bureaucracy

    30 апреля, 2026

    Biotech companies face the same dilemma as businesses in other industries: Innovation drops off dramatically with scale. European biotech Argenx has reached a market value of more than $40 billion, having so far escaped that innovation trap. How has it done this? The company shuns hierarchy and instead organizes into small teams, each dedicated to… →

    Management
  • Okta’s CRO: From $850M in Losses to $760M Profit (The AI Agent Bet) | Jon Addison

    30 апреля, 2026

    The GTM Podcast is available on any major directory, including: Apple Podcasts Spotify YouTube Okta’s CRO Jon Addison joins GTMnow host Sophie to break down the full story behind Okta’s remarkable revenue turnaround, the launch of Okta for AI Agents, and the go-to-market playbook that’s carrying them from $3B toward a $5B ARR target. From nearly $850M… →

    AI Sales
  • Streamlining Inherited Cancer Identification via an EMR-Integrated Risk Assessment Platform: A Nonrandomized Clinical Trial

    29 апреля, 2026

    CONCLUSIONS AND RELEVANCE: In this nonrandomized clinical trial, almost one-third of the population met national genetic counseling criteria for an inherited cancer syndrome, highlighting a substantial gap in usual care identification. Integrating patient-facing FHH collection and assessment tools for primary care patients improves inherited cancer risk identification and highlights opportunities to further enhance both risk… →

    Clinical Trials
1 2 3 … 950
Следующая страница